| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214182 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 24 Pages |
Abstract
According to the MDASI-HN, symptom burden was lower among the IMPT patients than among the IMRT patients during the subacute recovery phase after treatment. A prospective randomized clinical trial is underway to define the value of IMPT for the management of head and neck tumors.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Terence T. MD, MS, Huei-Kai MS, Qiuling PhD, G. Brandon MD, Charles S. PhD, J. Jack PhD, Mike MS, Pierre MD, PhD, Nikhil G. MD, Jack MD, PhD, David I. MD, Adam S. MD, William H. MD, C. David MD, PhD, Tito R. PhD, Radhe PhD, Xin Shelley MD, MPH,